Director’s Updates about Alzheimer's Disease

Find Director’s Updates by Topic

Jump to - Select a Topic - Attention Deficit Hyperactivity Disorder (ADHD) Anxiety Disorders Autism Bipolar Disorder Borderline Personality Disorder Depression Eating Disorders Generalized Anxiety Disorder Obsessive-Compulsive Disorder (OCD) Panic Disorder Post-Traumatic Stress Disorder Schizophrenia Social Anxiety Disorder Older Adults Men's Mental Health Women's Mental Health Children and Adolescents Basic Research Clinical Research and Trials Funding Mental Health Services Research Alzheimer's Disease Coping with Traumatic Events Diversity and Ethnic Groups Genetics HIV/AIDS Medications NIMH Prevention Psychotherapies Recovery Act Statistics Suicide Prevention Treatments

Or Find Director’s Updates by Year

2009 | 2008 | 2007 | 2006 | 2005

Director’s Updates about Alzheimer's Disease

NIMH Perspective on Treating Alzheimer’s Patients with Antipsychotic Medications

October 12, 2006
The recent publication of phase 1 results from the NIMH-funded Clinical Antipsychotic Trials in Intervention Effectiveness for Alzheimer's disease (CATIE-AD) in the New England Journal of Medicine provides new information about the use of several "atypical" antipsychotic medications for the treatment of psychotic symptoms in patients with Alzheimer's disease.

This page last reviewed: February 20, 2009

• Site Map
• Newsletters
• Staff Directories
• Contact NIMH
• Jobs
• Copyright
• Privacy Policy
• Policies
• FOIA